Review shows male circumcision protects female partners from HIV and other STDs

February 08, 2006

A statistical review of the past medical files of more than 300 couples in Uganda, in which the female partner was HIV negative and the male was HIV positive, provides solid documentation of the protective effects of male circumcision in reducing the risk of infection among women. Male circumcision also reduced rates of trichomonas and bacterial vaginosis in female partners. The study is believed to be the first to demonstrate the benefits to female partners of male circumcision.

Specifically, male circumcision reduced by 30 percent the likelihood that the female partner would become infected with the virus that causes AIDS, with 299 women contracting HIV from uncircumcised partners and only 44 women becoming infected by circumcised men. Similar reductions in risk were observed for the other two kinds of infection, but not for other common STDs, including human papillomavirus, syphilis, gonorrhea and Chlamydia.

According to the Hopkins researchers who led the study, Ronald Gray, M.D., and Steven Reynolds, M.D., M.P.H., the findings support efforts to assess male circumcision as an effective means of preventing HIV infection. Circumcision is a practice common in North America and among Jews and Muslims, but not generally in Eastern and Southern Africa, Europe or Asia.

The couples in the study come from the Rakai cohort, a population of roughly 12,000 in Uganda whom researchers are monitoring to see how HIV infection spreads. The researches based their findings on extensive interviews with each participant and annual check-ups and blood tests.

The findings confirm what has been noticed anecdotally in Africa, where regions in which circumcision is common have lower rates of HIV infection than those without. And, the results confirm what was first reported in summer 2005 from a clinical trial conducted in South Africa about the protective effects of circumcision on HIV-negative men who have sex with HIV-positive women.

According to researchers, circumcision's effects come from the nature of the foreskin's inner lining, or mucosa, whose cells bind to the virus more easily and have roughly nine times more virus in them than the outer layer of the foreskin. Removal of the foreskin, they say, may simply reduce the susceptibility factor, or degree of exposure to HIV, for the sexual partner.

Thomas C. Quinn, M.D., professor of infectious diseases at Hopkins and a senior investigator at the National Institute of Allergy and Infectious Disease, will present an overview of this trial, plus two others presently under way, as part of a plenary discussion at CROI on circumcision and HIV. But, he says, "We will have to wait for the ongoing two trials before drawing conclusive recommendations about circumcision for all men, and whether or not the benefits apply to transmission from females to males only, or to females from men as well. However, early indications are dramatic and, if proven, one case of HIV disease could be prevented through circumcising anywhere from 15 to 60 males."

Male Circumcision and the Risks of Female HIV and STI Acquisition in Rakai, Uganda, by Ronald Gray, Marie Thoma, Oliver Laeyendecker, David Serwadda, Fred Nalugoda, Godfrey Kigozi, Noah Kiwanuka, Nelson Sewankambo, Steven Reynolds, Maria Wawer, and Thomas Quinn. And, Circumcision and HIV Transmission:The Cutting Edge, by Thomas Quinn.
-end-
2006 Conference on Retroviruses and Opportunistic Infections, Feb. 5 - Feb. 9, Denver, Colo.

(Embargoed for release at 11:15 a.m. MT/1:15 p.m. ET, Wednesday, Feb. 8; oral presentation #127, Session 33, Ballrooms 1 and 2; preceded by plenary discussion at 8:30 a.m. MT, Main Lecture Hall, Colorado Convention Center)

Johns Hopkins Medicine

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.